Immunity boosting effect of Amukkara churanam Siddha drug for the frontliners of COVID health care
- Registration Number
- CTRI/2022/03/041406
- Lead Sponsor
- Ministry of AYUSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Presently not affected with COVID-19 infection or its possible symptoms
Adult Male or Female subjects above the age of 18 to 60 years.
After one month of COVID Vaccination
After three months of COVID Infection
The people who have not been vaccinated shall also be recruited in the trial. However, these participants would not be denied of the COVID-19 vaccination at any point of time during the trial.
Subjects who are at work for at least past 6 months in the health care facility where confirmed cases are identified and treated.
Willing and able to comply with survey completion, scheduled visits, treatment plan, and other study procedures
Subjects who are Competent and capable to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study
Currently hospitalized
Symptomatic with subjective fever, cough, or sore throat
Patients with other systemic malignant diseases
any medical or surgical condition
Concomitant use of any other significant medications/ chemoprophylaxis
immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method